Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000654565 | SCV000776459 | uncertain significance | Multiple endocrine neoplasia, type 2 | 2017-09-17 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with RET-related disease. This sequence change replaces phenylalanine with leucine at codon 285 of the RET protein (p.Phe285Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV000654565 | SCV005430308 | uncertain significance | Multiple endocrine neoplasia, type 2 | 2024-05-09 | criteria provided, single submitter | clinical testing |